In the days since Prime Minister Justin Trudeau announced he'll be stepping down as leader, the list of potential candidates ...

REVEAL study for iodine 124I-evuzamitide (AT-01) in patients with suspected cardiac amyloidosis has begun enrollment by Brigham and ...

With Watchman, Boston Scientific estimates a 20% compound annual growth rate (CAGR) in 2025 with a high market share. Mahoney ...

Moody National Bank Trust Division acquired a new stake in Boston Scientific Co. (NYSE:BSX – Free Report) during the 4th ...

Boston Scientific outperforms competitors with strong growth in atrial fibrillation devices and recent acquisitions. Learn ...

Shares of Boston Scientific Corp. BSX advanced 1.30% to $96.89 Wednesday, on what proved to be an all-around great trading ...

On the financial side, the company reported strong third-quarter 2024 results, with net sales of $4.209 billion — a 19.4% ...

Shares of Boston Scientific Co. (NYSE:BSX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the twenty ...

Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based ...

Boston Scientific Corp (BSX) stock saw a modest uptick, ending the day at $95.65 which represents a slight increase of $1.04 or 1.10% from the prior close of $94.61. The stock opened at $95.08 and ...

Boston Scientific Corp (BSX) stock saw a decline, ending the day at $94.88 which represents a decrease of $-1.07 or -1.12% from the prior close of $95.95. The stock opened at $95.48 and touched a low ...

Boston Scientific initially developed the concept for the Bolt IVL system, which is engineered to fracture calcium using ...